Mikko Airavaara Selected Research

Mikko Airavaara Research Topics

Disease

21	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2011
13	Stroke (Strokes) 01/2021 - 01/2011
7	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 01/2010
5	Infarction (Infarctions) 01/2020 - 07/2009
4	Brain Injuries (Brain Injury) 10/2017 - 07/2009
3	Neoplasms (Cancer) 11/2020 - 05/2007
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018 - 01/2013
3	Ischemia 01/2014 - 09/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
2	Neuralgia (Stump Neuralgia) 11/2020 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 10/2017
2	Hyperalgesia 01/2019 - 01/2018
2	Huntington Disease (Huntington's Disease) 12/2011 - 01/2011
2	Alzheimer Disease (Alzheimer's Disease) 12/2011 - 01/2011
2	Multiple Endocrine Neoplasia Type 2b (MEN 3) 06/2008 - 05/2007
1	Gliosis 01/2022
1	Synucleinopathies 01/2021
1	Rheumatoid Arthritis 11/2020
1	Multiple Sclerosis 11/2020
1	Opiate Overdose 03/2018
1	Ischemic Stroke 03/2018
1	Reperfusion Injury 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Neuroblastoma 02/2013
1	Infections 01/2013
1	Brain Diseases (Brain Disorder) 12/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2011
1	Brain Ischemia (Cerebral Ischemia) 07/2009
1	Necrosis 07/2009
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 05/2007

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2007
12	Nerve Growth Factors (Neurotrophins)IBA 06/2022 - 07/2009
11	Dopamine (Intropin)FDA LinkGeneric 06/2022 - 05/2007
6	SynucleinsIBA 01/2022 - 01/2020
4	Oxidopamine (6 Hydroxydopamine)IBA 01/2019 - 04/2016
3	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2019 - 05/2007
3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2018 - 12/2011
3	Messenger RNA (mRNA)IBA 12/2011 - 05/2007
2	LigandsIBA 01/2020 - 01/2014
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 03/2018 - 10/2017
2	Protein Isoforms (Isoforms)IBA 01/2018 - 12/2011
1	Insulin (Novolin)FDA Link 01/2022
1	Amyloidogenic ProteinsIBA 01/2022
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2021
1	Protein AggregatesIBA 01/2021
1	GuanosineIBA 01/2020
1	enhanced green fluorescent proteinIBA 01/2020
1	Adenine FDA LinkGeneric 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Calcium-Binding ProteinsIBA 01/2020
1	CeramidesIBA 01/2020
1	Culture MediaIBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	NeurotoxinsIBA 01/2020
1	SiliconIBA 01/2020
1	Sugar PhosphatesIBA 01/2020
1	Naloxone (Narcan)FDA LinkGeneric 03/2018
1	Opioid Receptors (Opioid Receptor)IBA 03/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	Recombinant ProteinsIBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2017
1	Alitretinoin FDA Link 01/2017
1	lactacystinIBA 01/2017
1	Bromodeoxyuridine (BrdU)IBA 01/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017
1	NeurturinIBA 12/2016
1	Hormones (Hormone)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016
1	IncretinsIBA 01/2016
1	Chemotactic FactorsIBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	Dietary ProteinsIBA 01/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2014
1	Amino Acids FDA Link 02/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2011
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2011
1	Glutamic Acid (Glutamate)FDA Link 01/2011
1	Neuroprotective AgentsIBA 07/2009
1	Arginine (L-Arginine)FDA Link 07/2009
1	triphenyltetrazoliumIBA 07/2009
1	Tetrabenazine (Nitoman)FDA Link 06/2008
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2008
1	alpha-Methyltyrosine (Metirosine)FDA Link 06/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2007
1	Cocaine (Cocaine HCl)IBA 05/2007

Therapy/Procedure

6	Therapeutics 11/2020 - 01/2010
1	Electrodes (Electrode) 01/2022
1	Intranasal Administration 03/2018
1	Injections 01/2018
1	Deep Brain Stimulation 01/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Vascular Surgical Procedures 01/2014
1	Diet Therapy (Therapy, Diet) 01/2014
1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2014